2016
DOI: 10.1038/bjc.2016.127
|View full text |Cite
|
Sign up to set email alerts
|

Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer

Abstract: Background:There are inconsistencies in the use of serum or plasma when analysing the matrix metalloproteinases (MMPs) as diagnostic or prognostic markers. The purpose of this study was to compare the concentration of MMP-1, -2, -7, -8, -9 and -13 in serum vs plasma samples.Methods:Blood samples were obtained from sixty-five men and women. Samples were analysed for levels of MMPs in corresponding citrate plasma and serum.Results:All MMPs expressed higher concentration in serum compared with plasma (P<0.01). Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(43 citation statements)
references
References 22 publications
1
38
0
2
Order By: Relevance
“…In addition, as there was only one study analysing each of soluble E-selectin, myeloperoxidase, plasminogen activator inhibitor-1 (PAI-1), soluble Intercellular Adhesion Molecule 1 (ICAM-1) and soluble Vascular cell adhesion protein 1 (VCAM-1) [18], carotid atherosclerosis indices (CAIs) [52], common carotid intima media thickness, plaque score and the presence of plaque in the common carotid [53], peripheral vascular disease [54,55] as well as some other CVD subtypes and clinic markers [21,27,[56][57][58][59][60][61], respectively, these variables have not been included in our dose-response meta-analysis. Moreover, due to the fact that significant differences could be found regarding concentrations of matrix-metalloproteases (MMPs) using plasma vs. serum [62], we further excluded two studies which analysed the plasma MMPs and serum MMPs respectively to avoid bias in outcome ascertainment [18,21] ( Figure S1). Two reviewers (LX and DM) independently reviewed the quality of the studies and differences were resolved by consensus and discussion.…”
Section: Data Sourcesmentioning
confidence: 99%
“…In addition, as there was only one study analysing each of soluble E-selectin, myeloperoxidase, plasminogen activator inhibitor-1 (PAI-1), soluble Intercellular Adhesion Molecule 1 (ICAM-1) and soluble Vascular cell adhesion protein 1 (VCAM-1) [18], carotid atherosclerosis indices (CAIs) [52], common carotid intima media thickness, plaque score and the presence of plaque in the common carotid [53], peripheral vascular disease [54,55] as well as some other CVD subtypes and clinic markers [21,27,[56][57][58][59][60][61], respectively, these variables have not been included in our dose-response meta-analysis. Moreover, due to the fact that significant differences could be found regarding concentrations of matrix-metalloproteases (MMPs) using plasma vs. serum [62], we further excluded two studies which analysed the plasma MMPs and serum MMPs respectively to avoid bias in outcome ascertainment [18,21] ( Figure S1). Two reviewers (LX and DM) independently reviewed the quality of the studies and differences were resolved by consensus and discussion.…”
Section: Data Sourcesmentioning
confidence: 99%
“…[ 16 ] Although a significant correlation was observed between MMP levels in plasma and serum, [ 17 ] the most recent studies recommend the use of plasma samples. [ 18 , 19 ] The techniques employed by different researchers included enzyme-linked immunosorbent assay (ELISA) or others immunological methods. In a few studies gelatinase activity was evaluated by zymography.…”
Section: Resultsmentioning
confidence: 99%
“…), which are released in the samples after venepuncture (Jonsson et al. ). Second, different immunoassays, with differences in reference as well as antibody affinity and avidity, lead to results that vary between the studies and complicate a direct comparison.…”
Section: Discussionmentioning
confidence: 99%